The Latest Breaking News from Oncology

Trial results presented at US oncology conference suggest ribociclib could be gamechanging and boost survival rate significantly

Pfizer (PFE) continues to make significant strides in the pharmaceutical industry, given its recent acquisition and drug approvals. Is the stock a buy, sell, or hold now? Keep reading to find out….

Stuck on the Syrian side of the border unable to return to Turkey, patients fret over how they will continue treatment.

The huge national shortage has left the hospital without the ability to recruit the staff needed

Katie Wilkins died after visiting the hospital on multiple occasions

Dr Khan is a Consultant Clinical Oncologist at Queen's Centre for Oncology and Haematology

The analysis came after its was revealed in 2019 that more than 300 patients, including 14 who have since died, were given reduced amounts of the treatment by doctors between December 2016 and March 2019

An 12-year-old boy's offer to cut off his mullet to raise money for two neighbours suffering from cancer leads to a successful community fundraiser in Broken Hill, with all monies to be donated to an oncology unit and lodge.

Biopharmaceutical giant Gilead Sciences (GILD) reported better-than-expected third-quarter earnings and sales and raised its full-year guidance. Analysts see immense growth potential in the company’s HIV and oncology franchises, which should boost its performance in the upcoming quarters. Given its strong earnings, high profitability, discounted valuation, and attractive dividend, we think…